Summary
65.01 -2.45(-3.63%)10/15/2024
CVS Health Corp (CVS)
CVS Health Corp (CVS)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -3.69 | -1.34 | 11.36 | 10.82 | -5.69 | -8.28 | 12.83 | 9,712.24 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 65.01 | |
| Open | 64.47 | |
| High | 66.09 | |
| Low | 63.60 | |
| Volume | 14,897,220 | |
| Change | -2.49 | |
| Change % | -3.69 | |
| Avg Volume (20 Days) | 10,507,710 | |
| Volume/Avg Volume (20 Days) Ratio | 1.42 | |
| 52 Week Range | 52.77 - 83.25 | |
| Price vs 52 Week High | -21.91% | |
| Price vs 52 Week Low | 23.19% | |
| Range | 0.84 | |
| Gap Up/Down | -3.33 | |
Fundamentals | ||
| Market Capitalization (Mln) | 74,233 | |
| EBIDTA | 16,924,000,256 | |
| PE Ratio | 9.7930 | |
| PEG Ratio | 0.9952 | |
| WallStreet Target Price | 68.76 | |
| Book Value | 59.0800 | |
| Earnings Per Share | 5.7000 | |
| EPS Estimate Current Quarter | 1.6900 | |
| EPS Estimate Next Quarter | 2.1900 | |
| EPS Estimate Current Year | 7.0000 | |
| EPS Estimate Next Year | 7.8000 | |
| Diluted EPS (TTM) | 5.7000 | |
| Revenues | ||
| Profit Marging | 0.0204 | |
| Operating Marging (TTM) | 0.0213 | |
| Return on asset (TTM) | 0.0318 | |
| Return on equity (TTM) | 0.1009 | |
| Revenue TTM | 359,661,993,984 | |
| Revenue per share TTM | 281.1510 | |
| Quarterly Revenue Growth (YOY) | 0.0360 | |
| Quarterly Earnings Growth (YOY) | -0.4670 | |
| Gross Profit (TTM) | 53,456,000,000 | |
| Dividends | ||
| Dividend Share | 2.4800 | |
| Dividend Yield | 0.0477 | |
| Valuations | ||
| Trailing PE | 9.7930 | |
| Forward PE | 8.2576 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.1315 | |
| Revenue Enterprise Value | 0.4317 | |
| EBITDA Enterprise Value | 8.4876 | |
| Shares | ||
| Shares Outstanding | 1,255,369,984 | |
| Shares Float | 1,251,845,374 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.01 | |
| Insider (%) | 0.12 | |
| Institutions (%) | 82.86 | |
10/15 11:40 EST - youtube.com
3 Stocks the Best Value Managers Are Buying
#Morningstar #ValueStocks #StockInvesting As value stocks rebound, here's where the smart money is investing. 00:00 Introduction 00:40 CVS CVS 01:39 Abbott ABT 02:26 Equifax EFX Susan Dziubsinki: I'm Susan Dziubinski with Morningstar.
3 Stocks the Best Value Managers Are Buying
#Morningstar #ValueStocks #StockInvesting As value stocks rebound, here's where the smart money is investing. 00:00 Introduction 00:40 CVS CVS 01:39 Abbott ABT 02:26 Equifax EFX Susan Dziubsinki: I'm Susan Dziubinski with Morningstar.
10/15 08:15 EST - marketbeat.com
CVS Health: Are Its Parts Worth More Than the Whole?
CVS Health Co. NYSE: CVStransformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company when it acquired Aetna Health Insurance for $70 billion on November 28, 2018. The plan was to offer the full gamut of healthcare services and products and grow its Minute Clinics around the country, cashing in on primary care services.
CVS Health: Are Its Parts Worth More Than the Whole?
CVS Health Co. NYSE: CVStransformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company when it acquired Aetna Health Insurance for $70 billion on November 28, 2018. The plan was to offer the full gamut of healthcare services and products and grow its Minute Clinics around the country, cashing in on primary care services.
10/15 07:30 EST - prnewswire.com
New CVS Health® report explores ongoing transformation of community pharmacy
CVS Health/Morning Consult survey reveals most pharmacy teams and consumers say more care and services can and should be provided in community pharmacy Demand for pharmacy care is high, with 76% of consumers having at least one prescription for themselves or a person they care for Most consumers (81%) say they trust their local pharmacist and 83% say their pharmacist's recommendations are important to them WOONSOCKET, R.I. , Oct. 15, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today released the Rx Report: Transforming Community Pharmacy to Make Healthier Happen Together , which explores the ongoing evolution of community pharmacy as well as opportunities for the industry to keep pace with consumer expectations, better support the workforce and advance the pharmacy model to create a more viable, sustainable future for the industry.
New CVS Health® report explores ongoing transformation of community pharmacy
CVS Health/Morning Consult survey reveals most pharmacy teams and consumers say more care and services can and should be provided in community pharmacy Demand for pharmacy care is high, with 76% of consumers having at least one prescription for themselves or a person they care for Most consumers (81%) say they trust their local pharmacist and 83% say their pharmacist's recommendations are important to them WOONSOCKET, R.I. , Oct. 15, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today released the Rx Report: Transforming Community Pharmacy to Make Healthier Happen Together , which explores the ongoing evolution of community pharmacy as well as opportunities for the industry to keep pace with consumer expectations, better support the workforce and advance the pharmacy model to create a more viable, sustainable future for the industry.
10/11 15:22 EST - reuters.com
Exclusive: CVS to exit core infusions services business, job cuts possible
CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, a company spokesperson confirmed to Reuters on Friday.
Exclusive: CVS to exit core infusions services business, job cuts possible
CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, a company spokesperson confirmed to Reuters on Friday.
10/11 12:45 EST - prnewswire.com
Aetna recommended for new D-SNP contract by the State of Michigan
Aetna to support more Michigan residents eligible for both Medicare and Medicaid DETROIT , Oct. 11, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced the State of Michigan has recommended the company for a new contract to serve MI Coordinated Health beneficiaries who are eligible for both Medicare and Medicaid. Aetna was selected as part of a competitive bidding process.
Aetna recommended for new D-SNP contract by the State of Michigan
Aetna to support more Michigan residents eligible for both Medicare and Medicaid DETROIT , Oct. 11, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced the State of Michigan has recommended the company for a new contract to serve MI Coordinated Health beneficiaries who are eligible for both Medicare and Medicaid. Aetna was selected as part of a competitive bidding process.
10/11 08:47 EST - barrons.com
Humana Stock Slumps. CVS and UnitedHealth Could Pick Up the Pieces.
Rival healthcare providers could gain from the cut in stars rating for Humana's Medicare plans.
Humana Stock Slumps. CVS and UnitedHealth Could Pick Up the Pieces.
Rival healthcare providers could gain from the cut in stars rating for Humana's Medicare plans.
10/10 19:00 EST - prnewswire.com
Aetna shines in Star Ratings with 88 percent of Medicare Advantage members in 4-star plans or higher for 2025
Exceptional service results in highest-ever Aetna member experience score WOONSOCKET, R.I. , Oct. 10, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that 88 percent of its Medicare Advantage (MA) members are in 2025 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS).
Aetna shines in Star Ratings with 88 percent of Medicare Advantage members in 4-star plans or higher for 2025
Exceptional service results in highest-ever Aetna member experience score WOONSOCKET, R.I. , Oct. 10, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that 88 percent of its Medicare Advantage (MA) members are in 2025 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS).
10/10 18:51 EST - zacks.com
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.
10/10 14:41 EST - benzinga.com
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgraded CVS Health Inc CVS on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage.
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgraded CVS Health Inc CVS on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage.
10/09 10:08 EST - zacks.com
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
10/09 06:03 EST - reuters.com
CVS, UnitedHealth ask for FTC's Khan and 2 commissioners to be disqualified from case
CVS Health and UnitedHealth Group have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
CVS, UnitedHealth ask for FTC's Khan and 2 commissioners to be disqualified from case
CVS Health and UnitedHealth Group have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
10/09 03:00 EST - barrons.com
Pfizer and CVS Are Attracting Activists. Healthcare Stocks Could Rebound.
Activists appear to be calling a bottom on the two stocks.
Pfizer and CVS Are Attracting Activists. Healthcare Stocks Could Rebound.
Activists appear to be calling a bottom on the two stocks.
10/08 09:00 EST - prnewswire.com
CVS Health supporting customers, patients, members and colleagues as Hurricane Milton approaches
WOONSOCKET, R.I. , Oct. 8, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for Hurricane Milton's landfall in Florida tomorrow.
CVS Health supporting customers, patients, members and colleagues as Hurricane Milton approaches
WOONSOCKET, R.I. , Oct. 8, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for Hurricane Milton's landfall in Florida tomorrow.
10/07 09:00 EST - prnewswire.com
CVS Health to hold third quarter 2024 earnings conference call
WOONSOCKET, R.I. , Oct. 7, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m.
CVS Health to hold third quarter 2024 earnings conference call
WOONSOCKET, R.I. , Oct. 7, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m.
10/06 07:45 EST - fool.com
Does This New Development Make CVS Stock a Buy or a Sell?
Major changes could soon be coming, but will they drive the stock up?
Does This New Development Make CVS Stock a Buy or a Sell?
Major changes could soon be coming, but will they drive the stock up?
10/05 11:09 EST - fool.com
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
The stock could be poised for a turnaround.
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
The stock could be poised for a turnaround.
10/05 05:21 EST - invezz.com
Why CVS Health stock could appreciate 35% from here
On October 4, 2024, TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a potential upside of 35%, driven by significant updates to CVS's Medicare Advantage (MA) business.
Why CVS Health stock could appreciate 35% from here
On October 4, 2024, TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a potential upside of 35%, driven by significant updates to CVS's Medicare Advantage (MA) business.
10/04 13:07 EST - fool.com
An Activist Investor Is Interested in CVS; We Take a Look
We also chat about Uber and its quest to become an everything app.
An Activist Investor Is Interested in CVS; We Take a Look
We also chat about Uber and its quest to become an everything app.
10/04 10:42 EST - schaeffersresearch.com
CVS Health Stock Bounces on Company Updates
Shares of CVS Health Corp (NYSE:CVS) are 3.9% higher to trade at $65.40 at last glance, after several updates for the healthcare giant.
CVS Health Stock Bounces on Company Updates
Shares of CVS Health Corp (NYSE:CVS) are 3.9% higher to trade at $65.40 at last glance, after several updates for the healthcare giant.